Clorox Co vs Cytokinetics Inc — how do they compare? Clorox Co trades at $108.39 (market cap $13.09B), while Cytokinetics Inc trades at $77.39 (market cap $10.63B). The key difference: Clorox Co is the larger of the two by market cap, and Clorox Co pays a 4.62% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CLX | CYTK | |
|---|---|---|
Market Cap | $13.09B | $10.63B |
Sector | Consumer Staples | Technology |
52-Week High | $127.16 | $87.26 |
52-Week Low | $86.12 | $34.31 |
Enterprise Value | $18.47B | $10.74B |
Dividend Yield | 4.62% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.
The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.
Trailing returns across standard periods
With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Read more on CLX →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →